Sermorelin Sleep Protocol
82
상호작용
2
300
beginner
May 17, 2026
개요
The Sermorelin Sleep Protocol leverages the natural relationship between growth hormone secretion and sleep architecture to enhance both simultaneously. Approximately 70% of daily GH secretion occurs during slow-wave (deep) sleep, and conversely, adequate GH signaling promotes deeper and more restorative sleep stages. Sermorelin is a 29-amino-acid GHRH analog that is identical to the first 29 amino acids of endogenous GHRH. It has a long clinical history, having been FDA-approved in the 1990s for pediatric GH deficiency, and has a long history of legal pharmacy compounding; it is not on the FDA Category 2 restricted-compounding list. When administered 30 minutes before bed on an empty stomach, Sermorelin amplifies the natural nocturnal GH surge that occurs approximately 60-90 minutes after sleep onset. This enhanced GH pulse deepens slow-wave sleep, which in turn promotes further GH release — creating a positive feedback loop. Low-dose Ipamorelin (100mcg) is added to amplify this pulse via ghrelin-receptor co-activation without doses high enough to cause any sleep-disrupting appetite signaling. The protocol is classified as beginner-friendly because Sermorelin has decades of clinical safety data, the doses are conservative, and the timing aligns with natural physiology rather than fighting it. Users typically report improvements in sleep quality within the first week, with deeper, less interrupted sleep and more vivid dreaming (indicating enhanced REM cycling). Over 4-8 weeks, the cumulative effect of improved nightly GH secretion manifests as better recovery, improved skin texture, modest fat reduction, and increased morning energy. This is an excellent entry point for individuals new to peptide therapy who want meaningful benefits with minimal complexity.
용량 프로토콜
200 mcg
1회 용량당
100 mcg
1회 용량당
목표 및 증거
경고
- Sermorelin is not on the FDA Category 2 restricted list and has a long history of legal pharmacy compounding. Ipamorelin remains FDA Category 2 (restricted) as of July 2026. Administer 30 min before bed on empty stomach.
Comments
Sign in to join the discussion
주의: 이 스택은 커뮤니티에서 제출된 것이며 연구용으로만 사용됩니다. Peptide Contacts는 제출된 스택의 안전성이나 효능을 검증하지 않습니다. 펩타이드 프로토콜을 사용하기 전에 항상 자격이 있는 의료 전문가와 상의하세요.